"An increasing challenge for drug manufacturers is budget constraints within public funding. New pricing models are providing pharmaceutical companies with flexible agreements that not only benefit both manufacturers and payers but can also speed up time to market. This is particularly relevant for highly innovative, high-cost products that can save lives."
Expert Profile
Learn how Georghia’s expertise can strengthen your market access strategy.
Download nowSpecialties
- Payer research
- Evidence generation
- Value messaging
- Product testing
- Market/competitor environment analysis
Biography
Georghia uses her natural talent for content development to successfully distill and communicate complex medical evidence and create compelling strategic messages that prioritize both the audience and client.
At Stratenym, Georghia has focused on developing reimbursement dossiers for orphan products in rare diseases.
Georghia supplements her academic experience in cardiology with extensive healthcare knowledge and 10+ years of experience writing for pharmaceutical companies, medical communication companies, and not-for-profit organizations. She has worked on numerous deliverables, including conference symposia, continuing medical education, publications, and slide decks in endocrinology, dermatology, gastroenterology, hematology, oncology, and rheumatology.
Georghia takes pride in producing clear, concise, and well-researched pieces. She has a keen eye for detail and high standards for integrity, originality, and adherence to deadlines. Having Georghia on a Stratenym project is a key indicator of project success.